David C Clay

age ~45

from Merritt Island, FL

Get Report

Also known as:

David M Clay
David C Caly

Connected to:

David Clay Phones & Addresses

Merritt Island, FL
586 Soapstone Ln, York, PA 17404
King of Prussia, PA
Bensalem, PA
Camillus, NY
Moravia, NY
Liverpool, NY
Goshen, NY
Provo, UT
Washington, DC
North Syracuse, NY

Medicine Doctors

David W. Clay

view source

Specialties:

Internal Medicine

Education:

Medical School
University of Arkansas College of Medicine at Little Rock
Graduated: 1992

Procedures:

Cardiac Stress Test
Continuous EKG
Destruction of Benign/Premalignant Skin Lesions
Electrocardiogram (EKG or ECG)
Pulmonary Function Tests
Vaccine Administration

Conditions:

Acute Bronchitis
Acute Pharyngitis
Acute Sinusitis
Acute Upper Respiratory Tract Infections
Alopecia Areata

Description:

Dr. Clay graduated from the University of Arkansas College of Medicine at Little Rock in 1992. He works in Fayetteville, AR and specializes in Internal Medicine. Dr. Clay is affiliated with Northwest Medical Center and Washington Regional Medical Center.

Name / Title

Company / Classification

Phones & Addresses

David Clay
Proprietor

LITTLE BUILDINGS FINE SCALE MODELS
Architects

2872 Inez Drive, Victoria, BC V9A 2J1
2503831793, 2503831799

David W. Clay
Director

Grace Baptist Church of Odessa

David Clay
Proprietor

LITTLE BUILDINGS FINE SCALE MODELS
Architects

2503831793, 2503831799

David L Clay

GLENCOE PROPERTIES, LTD

David L. Clay

POP AND MOM CULTURE, LLC

David A. Clay

SELECT CONSTRUCTION, INC

David D. Clay

TOTAL TOOLING, INC

David Clay

CLAY IMPRINTS LTD

Us Patents

Hemocompatibility Modifiers For Cross-Linked Polymeric Material
view source
US Patent:

20210402075, Dec 30, 2021
Filed:

May 6, 2021
Appl. No.:

17/313424
Inventors:

- Monmouth Junction NJ, US
Vincent J. Capponi - Lawrenceville NJ, US
David R. Clay - West Orange NJ, US
International Classification:

A61M 1/36
A61M 1/34
A61M 1/02
B01J 20/28
B01J 20/32
A01N 1/02
B01J 20/26
Abstract:

The invention concerns methods of removing undesirable molecules from the blood or physiologic fluid; said method comprising contacting said blood or physiologic fluid with a sorbent, said sorbent comprising a plurality of solid forms and comprising a cross-linked polymeric material having a plurality of ligands attached to the surface of said cross-linked polymeric material, comprising (i) zwitterionic moieties, (ii) oligo(ethylene glycol) moieties or (iii) mixtures thereof; said contacting comprising said sorbent sorbing a plurality of said undesirable molecules when said sorbent is administered within a patient's body.

Hemocompatibility Modifiers For Cross-Linked Polymeric Material
view source
US Patent:

20200246532, Aug 6, 2020
Filed:

Apr 17, 2020
Appl. No.:

16/851305
Inventors:

- Monmouth Junction NJ, US
Vincent J. Capponi - Lawrenceville NJ, US
David R. Clay - West Orange NJ, US
International Classification:

A61M 1/36
A61M 1/34
B01J 20/32
B01J 20/26
A01N 1/02
B01J 20/28
A61M 1/02
Abstract:

The invention concerns methods of removing undesirable molecules from the blood or physiologic fluid; said method comprising contacting said blood or physiologic fluid with a sorbent, said sorbent comprising a plurality of solid forms and comprising a cross-linked polymeric material having a plurality of ligands attached to the surface of said cross-linked polymeric material, comprising (i) zwitterionic moieties, (ii) oligo(ethylene glycol) moieties or (iii) mixtures thereof; said contacting comprising said sorbent sorbing a plurality of said undesirable molecules when said sorbent is administered within a patient's body.

Hemocompatibility Modifiers For Cross-Linked Polymeric Material
view source
US Patent:

20140294751, Oct 2, 2014
Filed:

Mar 31, 2014
Appl. No.:

14/230108
Inventors:

- Monmouth Junction NJ, US
Vincent J. Capponi - Monmouth Junction NJ, US
David R. Clay - West Orange NJ, US
Assignee:

CytoSorbents Corporation - Monmouth Junction NJ
International Classification:

A61M 1/36
A61K 31/785
A61K 31/765
A61M 1/34
US Classification:

424 7827, 210692, 210263, 424 7818
Abstract:

The invention concerns methods of treating blood, blood product, or physiologic fluid to provide at least one of (i) increasing shelf life of the blood, blood product or physiologic fluid, (ii) maintaining freshness of new blood, blood product or physiologic fluid, and (iii) removing undesirable molecules from the blood, blood product or physiologic fluid; said method comprising contacting said blood, blood product or physiologic fluid with a sorbent, said sorbent being primarily in a plurality of solid forms and comprising a cross-linked polymeric material having a plurality of at least one of (1) zwitterionic moieties and (2) oligo(ethylene glycol) moieties attached to the surface of said cross-linked polymeric material.